Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07660250 · ClinicalTrials.gov registry record · NA
Vagus Nerve Stimulation for Myelopathy
A NA study, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT07660250 is a NA study that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 36 participants.
The verdict
NCT07660250, a NA study, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The objective of this study is to generate preliminary data to establish the feasibility and effectiveness of transauricular vagus nerve stimulation (taVNS) to improve post-operative outcomes of moderate to severe degenerative cervical myelopathy (DCM)
Interventions
- DEVICE Sham Stimulation
- DEVICE Vagus nerve stimulation (taVNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-04-14 |
| Est. Completion | 2028-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07660250
The ClinicalTrials.gov registry entry for NCT07660250 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Stimulation is the first listed.
NCT07660250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07660250 about?
NCT07660250 is a clinical study titled "Vagus Nerve Stimulation for Myelopathy". The objective of this study is to generate preliminary data to establish the feasibility and effectiveness of transauricular vagus nerve stimulation (taVNS) to improve post-operative outcomes of moderate to severe degenerative cervical myelopathy (DCM)
What is the current status of trial NCT07660250?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2026-04-14. Estimated completion is 2028-05.
What interventions are being tested in trial NCT07660250?
The interventions under investigation include: Sham Stimulation (DEVICE), Vagus nerve stimulation (taVNS) (DEVICE).
Who is sponsoring clinical trial NCT07660250?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.